Ember Therapeutics Angles For Lead In ‘Brown Fat’ Therapeutics
This article was originally published in The Pink Sheet Daily
Executive Summary
Ember’s co-founder Bruce Spiegelman explained in the Banting Lecture at the American Diabetes Association earlier in June how his lab at Harvard discovered the hormone irisin, which appears to be a key regulator of fat metabolism and may be responsible for beneficial functions of ‘brown’ fat.